Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Outcome of Very Young (≤ 40 years) Patients with Immunoglobulin Light Chain Amyloidosis (AL): A Case Control Study

Jithma P Abeykoon, MD, Miriam Hobbs, CNP, Jonas Paludo, MD, Dirk R Larson, MS, Angela Dispenzieri, MD, Morie A. Gertz, MD, Francis K. Baudi, S. Vincent Rajkumar, MD, David Dingli, MD PhD FRCP, Wilson I Gonsalves, MD, Nelson Leung, MD, Robert A. Kyle, MD, Martha Q. Lacy, MD, Suzanne R. Hayman, MD, Taxiarchis Kourelis, MD, Yi Lin, MD PhD, Shaji Kumar, MD, Prashant Kapoor, MD

Blood (2016) 128 (22): 5576.

https://doi.org/10.1182/blood.V128.22.5576.5576

Published: 2016

Journal Articles

Risk of Monoclonal Gammopathy of Undetermined Significance in First-Degree Relatives of Multiple Myeloma Cases By Cytogenetic Subtype

Alyssa I. Clay, PhD, Abdul Rishi, MBBS, Shaji Kumar, MD, S. Vincent Rajkumar, MD, Alexandra J. Greenberg, PhD MPH, Dirk R Larson, MS, Megan M. O'Byrne, MS, Susan L. Slager, PhD, Celine M. Vachon, PhD

Blood (2016) 128 (22): 4425.

https://doi.org/10.1182/blood.V128.22.4425.4425

Published: 2016

Journal Articles

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

Ayalew Tefferi, Paola Guglielmelli, Dirk R. Larson, Christy Finke, Emnet A. Wassie, Lisa Pieri, Naseema Gangat, Rajmonda Fjerza, Alem A. Belachew, Terra L. Lasho, Rhett P. Ketterling, Curtis A. Hanson, Alessandro Rambaldi, Guido Finazzi, Juergen Thiele, Tiziano Barbui, Animesh Pardanani, Alessandro M. Vannucchi

Blood (2014) 124 (16): 2507–2513.

https://doi.org/10.1182/blood-2014-05-579136

Published: 2014

Includes: Supplemental data

Journal Articles

Progression in smoldering Waldenström macroglobulinemia: long-term results

Robert A. Kyle, Joanne T. Benson, Dirk R. Larson, Terry M. Therneau, Angela Dispenzieri, Shaji Kumar, L. Joseph Melton, III, S. Vincent Rajkumar

Blood (2012) 119 (19): 4462–4466.

https://doi.org/10.1182/blood-2011-10-384768

Published: 2012

Journal Articles

Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma

Rishi K. Wadhera, Robert A. Kyle, Dirk R. Larson, Angela Dispenzieri, Shaji Kumar, Hillard M. Lazarus, S. Vincent Rajkumar

Blood (2011) 118 (11): 2985–2987.

https://doi.org/10.1182/blood-2011-04-349175

Published: 2011

Journal Articles

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

Shaji Kumar, Angela Dispenzieri, Jerry A. Katzmann, Dirk R. Larson, Colin L. Colby, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Nelson Leung, Steve R. Zeldenrust, Marina Ramirez-Alvarado, Raynell J. Clark, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz

Blood (2010) 116 (24): 5126–5129.

https://doi.org/10.1182/blood-2010-06-290668

Published: 2010

Journal Articles

Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications

Giada Bianchi, Robert A. Kyle, Colin L. Colby, Dirk R. Larson, Shaji Kumar, Jerry A. Katzmann, Angela Dispenzieri, Terry M. Therneau, James R. Cerhan, L. Joseph Melton, III, S. Vincent Rajkumar

Blood (2010) 116 (12): 2019–2025.

https://doi.org/10.1182/blood-2010-04-277566

Published: 2010

Includes: Supplemental data

Journal Articles

The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma

Cheng E. Chee, Shaji Kumar, Dirk R. Larson, Robert A. Kyle, Angela Dispenzieri, Morie A. Gertz, Colin L. Colby, S. Vincent Rajkumar

Blood (2009) 114 (13): 2617–2618.

https://doi.org/10.1182/blood-2009-01-198788

Published: 2009

Journal Articles

Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance

Celine M. Vachon, Robert A. Kyle, Terry M. Therneau, Barbara J. Foreman, Dirk R. Larson, Colin L. Colby, Tara K. Phelps, Angela Dispenzieri, Shaji K. Kumar, Jerry A. Katzmann, S. Vincent Rajkumar

Blood (2009) 114 (4): 785–790.

https://doi.org/10.1182/blood-2008-12-192575

Published: 2009

Journal Articles

Increased Risk of Monoclonal Gammopathy in First-Degree Relatives of Patients with Multiple Myeloma or Monoclonal Gammopathy of Undetermined Significance.

Celine M Vachon, PhD, Robert Kyle, MD, Terry Therneau, PhD, Dirk R Larson, Colin Colby, Barbara J Foreman, Angela Dispenzieri, MD, Shaji Kumar, MD, Jerry Katzmann, MD, S. Vincent Rajkumar, MD

Blood (2008) 112 (11): 1672.

https://doi.org/10.1182/blood.V112.11.1672.1672

Published: 2008

Journal Articles

The Importance of Bone Marrow Examination in Determining Complete Response to Therapy in Patients with Multiple Myeloma.

Cheng E Chee, Shaji Kumar, Dirk R Larson, Robert A Kyle, Angela Dispenzieri, Morie A Gertz, Colin L Colby, S. Vincent Rajkumar

Blood (2008) 112 (11): 1730.

https://doi.org/10.1182/blood.V112.11.1730.1730

Published: 2008

Journal Articles

Accessory Splenectomy for Relapsed Idiopathic Thrombocytopenic Purpura.

Gita Thanarajasingam, Bsc, Alexandra P. Wolanskyj, M.D., Robert L. Phyliky, M.D., Dirk R. Larson, M.S.

Blood (2007) 110 (11): 3213.

https://doi.org/10.1182/blood.V110.11.3213.3213

Published: 2007

Journal Articles

Monoclonal Gammopathy of Undetermined Significance: Estimated Incidence and Duration Prior to Recognition.

Robert A. Kyle, Terry M. Therneau, Lee J. Melton, III, Angela Dispenzieri, Dirk R. Larson, Joanne T. Benson, Jerry A. Katzmann, S. Vincent Rajkumar

Blood (2007) 110 (11): 246.

https://doi.org/10.1182/blood.V110.11.246.246

Published: 2007

Journal Articles

Prognostic Value of the Serum Free Light Chain Ratio in Patients with Newly Diagnosed Myeloma: Proposed Incorporation into the International Staging System.

Christine L.H. Snozek, PhD, Jerry A. Katzmann, PhD, Robert A. Kyle, MD, Angela Dispenzieri, MD, Dirk R. Larson, Raynell J. Clark, Philip R. Greipp, MD, S. Vincent Rajkumar, MD

Blood (2007) 110 (11): 659.

https://doi.org/10.1182/blood.V110.11.659.659

Published: 2007

Journal Articles

A Study of Bedside Visual Art To Decrease Anxiety and Improve Pain and Mood in Cancer Patients: The Mayo Clinic Experience.

Alexandra P. Wolanskyj, MD, Elizabeth A. Curry, M.A., Shawna L. Ehlers, Ph.D., Debra M. Eagle, MBA, Dirk R. Larson, M.S., Colin L. Colby, M.S., Brent A. Bauer, M.D., Paul D. Scanlon, M.D.

Blood (2007) 110 (11): 975.

https://doi.org/10.1182/blood.V110.11.975.975

Published: 2007

Journal Articles

Elimination of the Need for Urine Studies during Diagnostic Studies of Monoclonal Gammopathies by the Combined Use of Serum Immunofixation and Serum Free Light Chain Assays.

Jerry A. Katzmann, PhD, Angela Dispenzieri, MD, Robert Kyle, MD, Melissa R. Snyder, PhD, Mathew F. Plevak, BS, Dirk R. Larson, MS, Roshini S. Abraham, PhD, John A. Lust, MD,PhD, L. Joseph Melton, MD, S. Vincent Rajkumar, MD

Blood (2006) 108 (11): 5011.

https://doi.org/10.1182/blood.V108.11.5011.5011

Published: 2006

Journal Articles

Immunoglobulin free light chains and solitary plasmacytoma of bone

David Dingli, Robert A. Kyle, S. Vincent Rajkumar, Grzegorz S. Nowakowski, Dirk R. Larson, John P. Bida, Morie A. Gertz, Terry M. Therneau, L. Joseph Melton, III, Angela Dispenzieri, Jerry A. Katzmann

Blood (2006) 108 (6): 1979–1983.

https://doi.org/10.1182/blood-2006-04-015784

Published: 2006

Journal Articles

Analysis of Survival, AML Transformation, and Transfusion Independence in Patients with High-Risk Myelodysplastic Syndromes (MDS) Receiving Azacitidine Determined Using a Prognostic Model.

Lewis R. Silverman, MD, David R. McKenzie, MS, Bercedis L. Peterson, PhD, Erin P. Demakos, RN, CCRC, James F. Holland, MD, Richard R. Larson, MD, The Cancer Leukemia Group B (CALGB).

Blood (2005) 106 (11): 2523.

https://doi.org/10.1182/blood.V106.11.2523.2523

Published: 2005

Journal Articles

Immunoglobulin Free Light Chains at Diagnosis: Predictors of Progression and Survival in Solitary Plasmacytoma of Bone.

David Dingli, MD, PhD, Robert A. Kyle, MD, Vincent S. Rajkumar, MD, Grzegorz S. Nowakowski, MD, Dirk R. Larson, MS, John P. Bida, MA, Morie A. Gertz, MD, Angela Dispenzieri, MD, L. J. Melton, III, MD, Terry M. Therneau, PhD, Jerry A. Katzmann, PhD

Blood (2005) 106 (11): 5080.

https://doi.org/10.1182/blood.V106.11.5080.5080

Published: 2005

Journal Articles

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

S. Vincent Rajkumar, Robert A. Kyle, Terry M. Therneau, L. Joseph Melton, III, Arthur R. Bradwell, Raynell J. Clark, Dirk R. Larson, Matthew F. Plevak, Angela Dispenzieri, Jerry A. Katzmann

Blood (2005) 106 (3): 812–817.

https://doi.org/10.1182/blood-2005-03-1038

Published: 2005

NARROW

Outcome of Very Young (≤ 40 years) Patients with Immunoglobulin Light Chain Amyloidosis (AL): A Case Control Study

Risk of Monoclonal Gammopathy of Undetermined Significance in First-Degree Relatives of Multiple Myeloma Cases By Cytogenetic Subtype

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

Progression in smoldering Waldenström macroglobulinemia: long-term results

Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications

The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma

Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance

Increased Risk of Monoclonal Gammopathy in First-Degree Relatives of Patients with Multiple Myeloma or Monoclonal Gammopathy of Undetermined Significance.

The Importance of Bone Marrow Examination in Determining Complete Response to Therapy in Patients with Multiple Myeloma.

Accessory Splenectomy for Relapsed Idiopathic Thrombocytopenic Purpura.

Monoclonal Gammopathy of Undetermined Significance: Estimated Incidence and Duration Prior to Recognition.

Prognostic Value of the Serum Free Light Chain Ratio in Patients with Newly Diagnosed Myeloma: Proposed Incorporation into the International Staging System.

A Study of Bedside Visual Art To Decrease Anxiety and Improve Pain and Mood in Cancer Patients: The Mayo Clinic Experience.

Elimination of the Need for Urine Studies during Diagnostic Studies of Monoclonal Gammopathies by the Combined Use of Serum Immunofixation and Serum Free Light Chain Assays.

Immunoglobulin free light chains and solitary plasmacytoma of bone

Analysis of Survival, AML Transformation, and Transfusion Independence in Patients with High-Risk Myelodysplastic Syndromes (MDS) Receiving Azacitidine Determined Using a Prognostic Model.

Immunoglobulin Free Light Chains at Diagnosis: Predictors of Progression and Survival in Solitary Plasmacytoma of Bone.

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only